CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Management of No-Reflow Phenomenon in the Catheterization Laboratory Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion The REVASC Trial ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

Review ArticleVolume 10, Issue 3, February 2017

JOURNAL:JACC: Cardiovascular Interventions Article Link

Management of No-Reflow Phenomenon in the Catheterization Laboratory

Rezkalla SH, Stankowski RV, Hanna J et al. Keywords: ST-segment elevation myocardial infarction; no-reflow; percutaneous coronary intervention

FULL TEXT PDF